Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$0.98 USD
0.00 (-0.22%)
Updated May 13, 2024 04:00 PM ET
After-Market: $0.99 +0.01 (0.79%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Rigel Pharmaceuticals, Inc. [RIGL]
Reports for Purchase
Showing records 81 - 100 ( 112 total )
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
3Q16: Awaiting FDA Feedback on Fostas ITP Regulatory Package
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Fosta Misses Primary Endpoint in Second Pivotal ITP Trial; Lowering PT to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Streamlining Operations to Focus Efforts on Anticipated Fosta Launch
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Fosta Shows Promise in Pivotal ITP Trial; Raising PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
2Q16: Awaiting Phase 3 Fosta Data Later This Month
Provider: H.C. Wainwright & Co., Inc.
Analyst: DEEPAK S
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Initiating Coverage with a Buy Ahead of Fosta Trial Readouts in 2H16
Provider: H.C. Wainwright & Co., Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Rigel Pharmaceuticals, Inc.
Industry: Medical - Drugs
Initiation of Coverage with a Buy rating and $15 price target.
Provider: Roth Capital Partners, Inc.
Analyst: HAZLETT R